Biocon - Global Healthcare Company
 
About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
 
  About Us
  Research & Development
  Branded Formulations
  Financial Results
  - Transcript of the call Q1FY15
  - Annual Report 2014
  - Investor Presentation
  Facilities Virtual Tour
  - Biocon
  - Syngene
  - Clinigene
  Downloads
  - Biocon Profile
  - CMD Profile
  - Video Gallery

Results of e-Voting
- Annual General Meeting -

for more details, please visit:
www.bioconacademy.com

Write to:
admissions@bioconacademy.com


     
  Biocon is an emerging global biopharmaceutical enterprise

focused on delivering affordable innovation. It is committed to

reduce therapy costs of chronic diseases like diabetes, cancer

and autoimmune diseases by leveraging India's cost advantage

to deliver affordable healthcare solutions to patients, partners

and healthcare systems across the globe.


 
   
   
   
   
Key Highlights - Q1 FY'15 Results
Stock Update
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Latest Press Release
 

Aug 10, 2014
Biocon to Mark a Decade of Excellence in Affordable Insulin Therapy...

  Media Coverage
 

Jul 26, 2014
Financial Express:
Biocon net rises 9% on licensing income...

Jul 26, 2014
DNA:
Biocon files first new drug applications...

 

Biocon Foundation


Arogya Raksha Yojana


Biocon Malaysia

 

          Patient Contact

          Patient Contact

 

 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Clinigene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer | Authorised Users               © 2014, Biocon. All Rights Reserved